• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 4 filed by President and CEO Gupta Rohit

    6/23/26 4:08:44 PM ET
    $ACT
    Specialty Insurers
    Finance
    Get the next $ACT alert in real time by email
    SEC FORM 4SEC Form 4
    FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number:3235-0287
    Estimated average burden
    hours per response:0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Gupta Rohit

    (Last)(First)(Middle)
    C/O ENACT HOLDINGS, INC.
    8325 SIX FORKS ROAD

    (Street)
    RALEIGH NORTH CAROLINA 27615

    (City)(State)(Zip)

    UNITED STATES

    (Country)
    2. Issuer Name and Ticker or Trading Symbol
    Enact Holdings, Inc. [ ACT ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    XDirector10% Owner
    XOfficer (give title below)Other (specify below)
    President and CEO
    2a. Foreign Trading Symbol
    3. Date of Earliest Transaction (Month/Day/Year)
    06/18/2026
    6. Individual or Joint/Group Filing (Check Applicable Line)
    XForm filed by One Reporting Person
    Form filed by More than One Reporting Person
    4. If Amendment, Date of Original Filed (Month/Day/Year)

    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    CodeVAmount(A) or (D)Price
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
    Restricted Stock Units(1)06/18/2026A107 (2) (2)Common Stock107$0(3)18,966D
    Restricted Stock Units(1)06/18/2026A173 (4) (4)Common Stock173$0(3)30,717D
    Restricted Stock Units(1)06/18/2026A217 (5) (5)Common Stock217$0(3)38,506D
    Explanation of Responses:
    1. Each restricted stock unit will settle into shares of Issuer common stock on a 1:1 basis.
    2. Restricted Stock Units vest and convert to Common Stock in three equal annual installments beginning on February 16, 2025.
    3. Additional restricted stock units acquired pursuant to reinvestment terms in the restricted stock unit award agreement resulting from a quarterly dividend at $0.24 per share, paid on June 18, 2026.
    4. Restricted Stock Units vest and convert to Common Stock in three equal annual installments beginning on February 21, 2026.
    5. Restricted Stock Units vest and convert to Common Stock in three equal annual installments beginning on February 13, 2027.
    Remarks:
    /s/ Joe Jacumin, by power of attorney06/23/2026
    ** Signature of Reporting PersonDate
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    * Form 4: SEC 1474 (03-26)
    Get the next $ACT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACT

    DatePrice TargetRatingAnalyst
    6/25/2026$47.00Sector Perform
    RBC Capital Mkts
    5/5/2025$39.00Outperform → Mkt Perform
    Keefe Bruyette
    12/6/2023$29.00Neutral
    UBS
    11/13/2023$30.00Neutral → Buy
    BofA Securities
    5/9/2023$25.00 → $27.00Underperform → Neutral
    BofA Securities
    2/8/2023$25.00 → $26.50Mkt Perform → Outperform
    Keefe Bruyette
    1/9/2023$24.50Neutral → Underperform
    Credit Suisse
    9/6/2022$27.00Overweight → Neutral
    JP Morgan
    More analyst ratings

    $ACT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Enact to Host Second Quarter 2026 Earnings Call August 6th

    RALEIGH, N.C., July 09, 2026 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (NASDAQ:ACT) (Enact) announced it will issue its second quarter earnings release after the market closes on August 5, 2026. Enact will host a conference call to review second quarter 2026 financial results on August 6, 2026 at 8:00 a.m. (ET). Enact’s earnings release, summary presentation and financial supplement will be available through the company's website, https://ir.enactmi.com, at the time of their release to the public. Participants interested in joining the call’s live question and answer session are required to pre-register by clicking here to obtain a dial-in number and unique PIN. It is recommended to join

    7/9/26 4:20:00 PM ET
    $ACT
    Specialty Insurers
    Finance

    Genworth Financial Schedules Earnings Conference Call for August 6

    Genworth Financial, Inc. (NYSE:GNW) today announced it will issue its earnings release containing second quarter results after the market closes on August 5, 2026. A conference call will be held on August 6, 2026, at 10:00 a.m. (ET) to discuss the quarter’s results.Genworth’s earnings release, summary presentation and financial supplement will be available through the company's website, http://investor.genworth.com, at the time of their release to the public.Genworth’s conference call will be accessible via telephone and internet. The dial-in number for Genworth’s August 6 conference call is 800-330-6710 or 213-279-1505 (outside the U.S.); conference ID #2307160. To participate in the call b

    7/9/26 4:15:00 PM ET
    $GNW
    $ACT
    Life Insurance
    Finance
    Specialty Insurers

    Genworth Financial President & CEO Thomas J. McInerney to Take Temporary Leave of Absence; Jerome Upton, Genworth CFO, Named Interim President & CEO

    Genworth Financial, Inc. (NYSE:GNW) today announced that Tom McInerney, President & Chief Executive Officer, will be taking a temporary leave of absence from his role to focus on his health. The Board of Directors has named Jerome Upton, currently Genworth’s Chief Financial Officer, as Interim President & Chief Executive Officer, effective immediately. "Our thoughts are with Tom and his family as he recovers, and we look forward to his return," said Melina Higgins, Genworth’s Board Chair. "Genworth is well positioned for continued success with a strong bench of talented leaders. Together with the Board and executive leadership team, I am confident that we will continue during this interim

    7/7/26 4:10:00 PM ET
    $GNW
    $ACT
    Life Insurance
    Finance
    Specialty Insurers

    $ACT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    RBC Capital Mkts initiated coverage on Enact Holdings with a new price target

    RBC Capital Mkts initiated coverage of Enact Holdings with a rating of Sector Perform and set a new price target of $47.00

    6/25/26 8:37:28 AM ET
    $ACT
    Specialty Insurers
    Finance

    Enact Holdings downgraded by Keefe Bruyette with a new price target

    Keefe Bruyette downgraded Enact Holdings from Outperform to Mkt Perform and set a new price target of $39.00

    5/5/25 8:29:05 AM ET
    $ACT
    Specialty Insurers
    Finance

    UBS initiated coverage on Enact Holdings with a new price target

    UBS initiated coverage of Enact Holdings with a rating of Neutral and set a new price target of $29.00

    12/6/23 7:20:51 AM ET
    $ACT
    Specialty Insurers
    Finance

    $ACT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Genworth Holdings, Inc. sold $25,580,418 worth of shares (605,067 units at $42.28) (SEC Form 4)

    4 - Enact Holdings, Inc. (0001823529) (Issuer)

    7/1/26 4:16:50 PM ET
    $ACT
    Specialty Insurers
    Finance

    SEC Form 4 filed by EVP & Chief Operations Officer Gould Brian

    4 - Enact Holdings, Inc. (0001823529) (Issuer)

    6/23/26 4:09:34 PM ET
    $ACT
    Specialty Insurers
    Finance

    SEC Form 4 filed by Director Bless Michael A

    4 - Enact Holdings, Inc. (0001823529) (Issuer)

    6/23/26 4:09:28 PM ET
    $ACT
    Specialty Insurers
    Finance

    $ACT
    SEC Filings

    View All

    Enact Holdings Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - Enact Holdings, Inc. (0001823529) (Filer)

    5/15/26 4:01:34 PM ET
    $ACT
    Specialty Insurers
    Finance

    SEC Form 10-Q filed by Enact Holdings Inc.

    10-Q - Enact Holdings, Inc. (0001823529) (Filer)

    5/6/26 4:44:38 PM ET
    $ACT
    Specialty Insurers
    Finance

    Enact Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Enact Holdings, Inc. (0001823529) (Filer)

    5/5/26 4:23:06 PM ET
    $ACT
    Specialty Insurers
    Finance

    $ACT
    Leadership Updates

    Live Leadership Updates

    View All

    Enact Holdings Set to Join S&P SmallCap 600

    NEW YORK, April 9, 2025 /PRNewswire/ -- Enact Holdings Inc. (NASD: ACT) will replace SolarWinds Corp. (NYSE:SWI) in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, April 16. Turn/River Capital is acquiring SolarWinds in a deal expected to close soon, pending final closing conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name Action Company Name Ticker GICS Sector April 16, 2025 S&P SmallCap 600 Addition Enact Holdings ACT Financials April 16, 2025 S&P SmallCap 600 Deletion SolarWinds SWI Information Technology For more information about S&P Dow Jones Indices, please vi

    4/9/25 5:42:00 PM ET
    $ACT
    $SPGI
    $SWI
    Specialty Insurers
    Finance
    Finance: Consumer Services
    Computer Software: Prepackaged Software

    Enact Announces Changes to its Board of Directors

    RALEIGH, N.C., March 11, 2025 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (NASDAQ:ACT) (Enact) today announced that it has appointed H. Elizabeth (Liz) Mitchell as an Independent Director to serve on Enact's Board of Directors, effective March 11, 2025. She has also been appointed as a member of the Audit Committee. In addition, the company announced that Anne G. Waleski has made the decision not to stand for re-election at the 2025 Annual Shareholder Meeting on May 14, 2025. As a result of these actions, Enact's Board will temporarily increase in size from eleven to twelve directors until the company's 2025 Annual Shareholder Meeting. Ms. Mitchell brings deep financial, industry and public

    3/11/25 4:15:00 PM ET
    $ACT
    Specialty Insurers
    Finance

    $ACT
    Financials

    Live finance-specific insights

    View All

    Enact to Host Second Quarter 2026 Earnings Call August 6th

    RALEIGH, N.C., July 09, 2026 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (NASDAQ:ACT) (Enact) announced it will issue its second quarter earnings release after the market closes on August 5, 2026. Enact will host a conference call to review second quarter 2026 financial results on August 6, 2026 at 8:00 a.m. (ET). Enact’s earnings release, summary presentation and financial supplement will be available through the company's website, https://ir.enactmi.com, at the time of their release to the public. Participants interested in joining the call’s live question and answer session are required to pre-register by clicking here to obtain a dial-in number and unique PIN. It is recommended to join

    7/9/26 4:20:00 PM ET
    $ACT
    Specialty Insurers
    Finance

    Genworth Financial Schedules Earnings Conference Call for August 6

    Genworth Financial, Inc. (NYSE:GNW) today announced it will issue its earnings release containing second quarter results after the market closes on August 5, 2026. A conference call will be held on August 6, 2026, at 10:00 a.m. (ET) to discuss the quarter’s results.Genworth’s earnings release, summary presentation and financial supplement will be available through the company's website, http://investor.genworth.com, at the time of their release to the public.Genworth’s conference call will be accessible via telephone and internet. The dial-in number for Genworth’s August 6 conference call is 800-330-6710 or 213-279-1505 (outside the U.S.); conference ID #2307160. To participate in the call b

    7/9/26 4:15:00 PM ET
    $GNW
    $ACT
    Life Insurance
    Finance
    Specialty Insurers

    Enact Reports First Quarter 2026 Results

    GAAP Net Income of $168 million, or $1.18 per diluted shareAdjusted Operating Income of $172 million, or $1.21 per diluted shareReturn on Equity of 12.5% and Adjusted Operating Return on Equity of 12.9%Primary Insurance in-force of $272 billion, a 2% year-over-year increasePMIERs Sufficiency of 162% or approximately $1.9 billionBook Value Per Share of $38.09 and Book Value Per Share excluding AOCI of $38.68 RALEIGH, N.C., May 05, 2026 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (NASDAQ:ACT) today announced financial results for the first quarter of 2026. "Enact delivered a strong start to 2026, reflecting disciplined execution, resilient credit performance, and our continued focus on long-t

    5/5/26 4:20:00 PM ET
    $ACT
    Specialty Insurers
    Finance

    $ACT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Enact Holdings Inc. (Amendment)

    SC 13G/A - Enact Holdings, Inc. (0001823529) (Subject)

    2/13/24 4:15:14 PM ET
    $ACT
    Specialty Insurers
    Finance

    SEC Form SC 13G/A filed by Enact Holdings Inc. (Amendment)

    SC 13G/A - Enact Holdings, Inc. (0001823529) (Subject)

    1/24/24 5:00:27 PM ET
    $ACT
    Specialty Insurers
    Finance

    SEC Form SC 13G/A filed by Enact Holdings Inc. (Amendment)

    SC 13G/A - Enact Holdings, Inc. (0001823529) (Subject)

    2/13/23 12:30:19 PM ET
    $ACT
    Specialty Insurers
    Finance